Celyad SA Valuation
| CYADDelisted Stock | USD 0.52 0.00 0.00% |
Celyad SA is overvalued. Celyad SA shows a prevailing Real Value of $0.41 per share. The current price of the firm is $0.52. Our model approximates the value of Celyad SA from analyzing the firm fundamentals such as Return On Equity of -1.71, shares owned by institutions of 29.16 %, and Current Valuation of (1.57 M) as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Celyad SA's price fluctuation is very steady at this time. Calculation of the real value of Celyad SA is based on 3 months time horizon. Increasing Celyad SA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Celyad stock is determined by what a typical buyer is willing to pay for full or partial control of Celyad SA. Since Celyad SA is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Celyad Stock. However, Celyad SA's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.52 | Real 0.41 | Hype 0.52 | Naive 0.54 |
The real value of Celyad Stock, also known as its intrinsic value, is the underlying worth of Celyad SA Company, which is reflected in its stock price. It is based on Celyad SA's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Celyad SA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Celyad SA helps investors to forecast how Celyad stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Celyad SA more accurately as focusing exclusively on Celyad SA's fundamentals will not take into account other important factors: Celyad SA Total Value Analysis
Celyad SA is currently forecasted to have valuation of (1.57 M) with market capitalization of 14.24 M, debt of 255 K, and cash on hands of 14.38 M. The negative valuation of Celyad SA may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Celyad SA fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(1.57 M) | 14.24 M | 255 K | 14.38 M |
Celyad SA Asset Utilization
One of the ways to look at asset utilization of Celyad is to check how much profit was generated for every dollar of assets it reports. Celyad SA shows a negative utilization of assets of -0.25 percent, losing $0.002541 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Celyad SA shows how discouraging it operates for each dollar spent on its assets.Celyad SA Ownership Allocation
Celyad SA holds a total of 22.59 Million outstanding shares. Almost 70.85 percent of Celyad SA outstanding shares are held by general public with 29.16 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Celyad SA Profitability Analysis
Net Loss for the year was (40.94 M) with profit before overhead, payroll, taxes, and interest of 5 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Celyad SA's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Celyad SA and how it compares across the competition.
About Celyad SA Valuation
The delisted stock valuation mechanism determines Celyad SA's current worth on a weekly basis. Our valuation model uses a comparative analysis of Celyad SA. We calculate exposure to Celyad SA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Celyad SA's related companies.Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T cell therapies for the treatment of cancer. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium. Celyad Sa operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 95 people.
Celyad SA Growth Indicators
Investing in growth stocks can be very risky. If the company such as Celyad SA does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 22.6 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Celyad Stock
If you are still planning to invest in Celyad SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Celyad SA's history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |